Exploring Health News: ‘Microdosing’ Candies, Illnesses, Deaths, and Advances in Alzheimer’s Drugs

Hello health and wellness enthusiasts! I’m Kaitlin, here to bring you up to speed on the latest health news you might have overlooked.

Let’s dive into what our team covered this week

Feeling the heat? A recent Yahoo News/YouGov poll revealed that 62% of Americans surveyed say extreme heat affects their mood. According to experts, there’s a scientific basis for this impact.

Mosquito bites are more than just irritating—they can be life-threatening. Natalie Rahhal discussed the rising threat of mosquito-borne illnesses and how to safeguard against them.

Dry drowning has been a topic of confusion. Korin Miller clarified that it’s not a medical term and debunked some common misconceptions surrounding it.

Ever heard of zombie cells? Natalie explored how eliminating these cells could potentially improve aging outcomes, a fascinating avenue of research.

In heartwarming news, a golden retriever brought joy as a therapy dog at the Olympic trials. Learn how these canine companions contribute to mental health treatment.

Here are other important stories you should know

FDA approval for a new Alzheimer’s drug:

The FDA recently greenlit Eli Lilly’s Alzheimer’s drug, donanemab, after clinical trials showed it slowed disease progression by approximately 35% over 18 months. Marketed as Kisunla, this monoclonal antibody targets amyloid plaques in the brain, offering hope to those with mild cognitive impairment.

This approval marks a significant advancement in Alzheimer’s treatment, providing patients and caregivers more time to make critical healthcare decisions. With Medicare likely to cover Kisunla, accessibility to cutting-edge treatments expands for Alzheimer’s sufferers.

Weight loss drugs and cancer risk

New research suggests GLP-1 medications like semaglutide (found in drugs like Ozempic and Wegovy) may lower the risk of obesity-related cancers among individuals with type-2 diabetes. However, concerns about potential side effects, including a rare eye condition, NAION, highlight the need for balanced considerations when using these medications.

The findings underscore the importance of ongoing research into the long-term effects of GLP-1 medications, offering insights into their broader health impacts beyond diabetes management.

Microdosing candies and health risks

Federal health authorities are investigating severe illnesses and a possible fatality linked to “microdosing” candies by Diamond Shruumz. These products contain muscimol, derived from the amanita mushroom, and are associated with alarming symptoms such as seizures and loss of consciousness.

While muscimol is legal in the U.S., incidents like these underscore the need for stricter regulation and deeper research into the safety of psychoactive substances used in consumer products.

Stay informed and stay healthy, everyone! Remember, your well-being matters, and knowledge is a powerful tool in making informed health choices.

Exit mobile version